TGFB1 and osteoarthritis: However, ISL could inhibit excessive release of TGF-β in bone marrow by suppression osteoclastogenesis through targeting RANKL-RANK-TRAF6 singling pathway in preosteoclast and therefore prevent a cascade of events that lead to the development of osteoarthritis (Fig. 9).